Swissquote, the Swiss online banking leader, today announced an addition to its list of prime partners.
Swissquote’s new funds prime partner Bellevue offers investors direct access via BB Biotech AG or UCITS funds to attractive portfolios of promising, fast-growing healthcare companies listed on stock markets around the world.
Bellevue is a specialized asset manager listed on the SIX Swiss Exchange with core competencies covering healthcare strategies, entrepreneur investments and selected niches strategies. Established in 1993, Bellevue, a House of Investment Ideas staffed by 100 professionals, generates attractive investment returns and creates value added for clients and shareholders alike. Bellevue managed assets of CHF 14.4 billion as at June 30, 2021.
Investment funds have a number of advantages over direct investment in securities. A fund invests in shares, bonds and various other products. Because the risk is spread across a range of investment products, the total risk is reduced.
Somebody who purchases a fund unit can invest in various categories simultaneously using a relatively small amount of money. Modern index funds, also known as ETFs, are directly tied to the performance of an index.
Swissquote offers over 20,000 investment funds from renowned fund management companies.